Company Filing History:
1 out of 274 
1 out of 2,104 
Years Active: 1997
Title: Antonis E Koromilas: Innovator in Anti-Tumor Research
Introduction
Antonis E Koromilas is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of cancer research, particularly through his innovative patent related to anti-tumor agents. His work focuses on the detection of neoplastic cells, which is crucial for early cancer diagnosis and treatment.
Latest Patents
Koromilas holds a patent for an "Anti-tumor agent assay using PKR." This method involves screening human tissue for the presence of neoplastic cells by determining the activity of PKR, P58, or anti-P58 in test cells. The identification of candidate neoplastic cells is based on subnormal activity of these proteins. The patent also includes assay kits designed for carrying out this screening method effectively.
Career Highlights
Throughout his career, Antonis E Koromilas has worked at prestigious institutions such as McGill University and the University of Washington. His research has contributed to advancements in understanding cancer biology and developing diagnostic tools.
Collaborations
Koromilas has collaborated with esteemed colleagues, including Nahum Sonenberg and Michael G Katze. These partnerships have enhanced the impact of his research and broadened the scope of his work in the scientific community.
Conclusion
Antonis E Koromilas is a distinguished inventor whose work in anti-tumor research has the potential to improve cancer detection and treatment. His innovative methods and collaborations reflect his commitment to advancing medical science.